1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Wan, Z.L.
Hua, Q.X.
Huang, K.
Hu, S.Q.
Philips, N.B.
Katsoyannis, J.W.
Weiss, M.A.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C3 H7 N O2
89.093
D-ALANINE
D-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
To be Published
0353
Chiral Protein Engineering and its Application in G Health
2383.698
Insulin A chain
UNP rsidues 90-110
P28K, K29P
1
man
polymer
3462.005
Insulin B chain
UNP rsidues 25-54
1
man
polymer
Insulin A chain
Insulin B chain
no
no
GIVEQCCTSICSLYQLENYCN
GIVEQCCTSICSLYQLENYCN
A
polypeptide(L)
no
yes
FVNQHLCGSHLVEALYLVC(DAL)ER(DAL)FFYTKPT
FVNQHLCGSHLVEALYLVCAERAFFYTKPT
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
sample
INS
9606
Homo sapiens
562
Escherichia coli
pBR322
human
sample
INS
9606
Homo sapiens
562
Escherichia coli
pBR322
repository
Initial release
1
0
2011-08-31
Residues 20 and 23 in chain B are engineered to be D-ALA.
BMRB
Y
RCSB
2010-08-09
REL
REL
THIS STRUCTURE WAS DETERMINED USING STANDARD 2D HOMONUCLEAR NMR TECHNIQUES.
STRUCTURES WITH THE LOWEST ENERG
40
20
2D TOCSY
NOESY
COSY
0.5
mM
7.0
mbar
298
K
DISTANCE GEOMETRY AND SIMULATED
1
closest to the average
0.5 mM entity_1-1, 90% H2O/10% D2O
90% H2O/10% D2O
Brunger
structure solution
X-PLOR
3.5
Brunger
refinement
X-PLOR
3.5
700
Bruker
DRX
BRUKER DRX
GLY
1
n
1
GLY
1
A
ILE
2
n
2
ILE
2
A
VAL
3
n
3
VAL
3
A
GLU
4
n
4
GLU
4
A
GLN
5
n
5
GLN
5
A
CYS
6
n
6
CYS
6
A
CYS
7
n
7
CYS
7
A
THR
8
n
8
THR
8
A
SER
9
n
9
SER
9
A
ILE
10
n
10
ILE
10
A
CYS
11
n
11
CYS
11
A
SER
12
n
12
SER
12
A
LEU
13
n
13
LEU
13
A
TYR
14
n
14
TYR
14
A
GLN
15
n
15
GLN
15
A
LEU
16
n
16
LEU
16
A
GLU
17
n
17
GLU
17
A
ASN
18
n
18
ASN
18
A
TYR
19
n
19
TYR
19
A
CYS
20
n
20
CYS
20
A
ASN
21
n
21
ASN
21
A
PHE
1
n
1
PHE
1
B
VAL
2
n
2
VAL
2
B
ASN
3
n
3
ASN
3
B
GLN
4
n
4
GLN
4
B
HIS
5
n
5
HIS
5
B
LEU
6
n
6
LEU
6
B
CYS
7
n
7
CYS
7
B
GLY
8
n
8
GLY
8
B
SER
9
n
9
SER
9
B
HIS
10
n
10
HIS
10
B
LEU
11
n
11
LEU
11
B
VAL
12
n
12
VAL
12
B
GLU
13
n
13
GLU
13
B
ALA
14
n
14
ALA
14
B
LEU
15
n
15
LEU
15
B
TYR
16
n
16
TYR
16
B
LEU
17
n
17
LEU
17
B
VAL
18
n
18
VAL
18
B
CYS
19
n
19
CYS
19
B
DAL
20
n
20
DAL
20
B
GLU
21
n
21
GLU
21
B
ARG
22
n
22
ARG
22
B
DAL
23
n
23
DAL
23
B
PHE
24
n
24
PHE
24
B
PHE
25
n
25
PHE
25
B
TYR
26
n
26
TYR
26
B
THR
27
n
27
THR
27
B
LYS
28
n
28
LYS
28
B
PRO
29
n
29
PRO
29
B
THR
30
n
30
THR
30
B
author_defined_assembly
2
dimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
B
B
O
H
VAL
TYR
12
16
1.45
1
A
A
O
H
ILE
CYS
2
6
1.56
1
B
B
O
H
SER
GLU
9
13
1.57
2
B
B
O
H
VAL
TYR
12
16
1.41
2
A
A
O
H
LEU
TYR
16
19
1.47
2
A
B
HD21
O
ASN
DAL
21
23
1.47
2
B
B
O
H
SER
GLU
9
13
1.53
3
B
B
O
H
VAL
TYR
12
16
1.45
3
A
B
O
H
CYS
LEU
6
6
1.48
3
A
A
O
H
ILE
GLN
2
5
1.50
3
B
B
O
H
SER
GLU
9
13
1.51
4
B
B
O
H
VAL
TYR
12
16
1.51
4
A
A
O
H
ILE
GLN
2
5
1.53
4
B
B
O
H
SER
GLU
9
13
1.56
5
B
B
O
H
VAL
TYR
12
16
1.44
5
A
A
O
H
ILE
GLN
2
5
1.46
5
B
B
O
H
SER
GLU
9
13
1.57
6
A
B
O
H
CYS
LEU
6
6
1.47
6
B
B
O
H
VAL
TYR
12
16
1.50
6
A
A
O
H
ILE
GLN
2
5
1.52
6
B
B
O
H
SER
GLU
9
13
1.60
7
B
B
O
H
VAL
TYR
12
16
1.41
7
A
B
O
H
CYS
LEU
6
6
1.46
7
A
A
O
H
ILE
GLN
2
5
1.49
7
B
B
O
H
SER
GLU
9
13
1.56
8
B
B
O
H
VAL
TYR
12
16
1.42
8
A
A
O
H
GLN
ASN
15
18
1.58
9
B
B
O
H
VAL
TYR
12
16
1.45
9
A
A
O
H
ILE
GLN
2
5
1.46
9
B
B
O
H
SER
GLU
9
13
1.53
9
A
B
O
H
CYS
LEU
6
6
1.53
10
B
B
O
H
VAL
TYR
12
16
1.43
10
A
A
O
H
ILE
GLN
2
5
1.50
10
B
B
O
H
SER
GLU
9
13
1.56
10
A
A
O
H
LEU
TYR
16
19
1.59
11
B
B
O
H
VAL
TYR
12
16
1.41
11
A
A
O
H
ILE
GLN
2
5
1.45
11
A
B
O
H
CYS
LEU
6
6
1.49
11
B
B
O
H
SER
GLU
9
13
1.57
11
A
B
HD21
O
ASN
DAL
21
23
1.58
12
B
B
O
H
VAL
TYR
12
16
1.39
12
B
B
O
H
SER
GLU
9
13
1.53
13
B
B
O
H
VAL
TYR
12
16
1.43
13
A
A
O
H
LEU
TYR
16
19
1.53
13
B
B
O
H
SER
GLU
9
13
1.54
14
B
B
O
H
VAL
TYR
12
16
1.44
14
A
A
O
H
ILE
GLN
2
5
1.46
14
A
B
O
H
CYS
LEU
6
6
1.48
14
B
B
O
H
SER
GLU
9
13
1.56
15
B
B
O
H
VAL
TYR
12
16
1.45
15
A
A
O
H
ILE
GLN
2
5
1.47
15
B
B
O
H
SER
GLU
9
13
1.56
16
B
B
O
H
VAL
TYR
12
16
1.40
17
B
B
O
H
VAL
TYR
12
16
1.43
17
A
A
O
H
ILE
GLN
2
5
1.49
17
B
B
O
H
SER
GLU
9
13
1.56
18
B
B
O
H
VAL
TYR
12
16
1.40
18
B
B
O
H
SER
GLU
9
13
1.59
19
B
B
O
H
VAL
TYR
12
16
1.43
19
A
A
O
H
ILE
GLN
2
5
1.47
19
B
B
O
H
SER
GLU
9
13
1.56
20
B
B
O
H
VAL
TYR
12
16
1.41
20
A
A
O
H
GLN
ASN
15
18
1.56
20
A
A
O
H
ILE
GLN
2
5
1.58
20
B
B
O
H
SER
GLU
9
13
1.58
1
B
ARG
22
0.315
SIDE CHAIN
2
B
ARG
22
0.096
SIDE CHAIN
3
B
ARG
22
0.305
SIDE CHAIN
4
B
ARG
22
0.263
SIDE CHAIN
5
B
ARG
22
0.212
SIDE CHAIN
6
B
ARG
22
0.291
SIDE CHAIN
7
B
ARG
22
0.318
SIDE CHAIN
8
B
ARG
22
0.179
SIDE CHAIN
9
B
ARG
22
0.298
SIDE CHAIN
10
B
ARG
22
0.217
SIDE CHAIN
11
B
ARG
22
0.280
SIDE CHAIN
12
B
ARG
22
0.265
SIDE CHAIN
13
B
ARG
22
0.160
SIDE CHAIN
14
B
ARG
22
0.297
SIDE CHAIN
15
B
ARG
22
0.314
SIDE CHAIN
16
B
ARG
22
0.272
SIDE CHAIN
18
B
ARG
22
0.235
SIDE CHAIN
19
B
ARG
22
0.275
SIDE CHAIN
20
B
ARG
22
0.307
SIDE CHAIN
1
A
SER
9
-88.27
-155.25
1
A
CYS
20
-69.97
-178.79
1
B
VAL
2
-143.38
13.44
1
B
ASN
3
-176.85
105.64
1
B
GLN
4
-160.21
56.26
1
B
CYS
19
-84.98
-79.73
1
B
GLU
21
-164.45
-41.97
1
B
PHE
24
-49.91
-176.85
2
A
CYS
7
-107.81
-66.50
2
A
SER
9
-117.04
-161.09
2
B
ASN
3
44.28
92.77
2
B
CYS
19
-105.83
-65.43
2
B
GLU
21
-165.62
-35.17
2
B
DAL
23
122.74
61.99
2
B
PHE
24
-54.98
-170.37
3
A
CYS
7
-133.11
-40.61
3
A
CYS
20
-53.13
176.72
3
B
VAL
2
-160.13
-159.97
3
B
DAL
20
89.37
-49.26
3
B
ARG
22
-141.50
-75.44
3
B
DAL
23
134.79
59.55
3
B
PHE
24
-53.69
-171.81
4
B
GLN
4
-160.10
103.25
4
B
CYS
7
-126.93
-169.41
4
B
GLU
21
176.62
72.07
4
B
ARG
22
-175.22
-62.69
4
B
PHE
24
-51.57
-176.02
5
A
CYS
7
-132.18
-63.36
5
A
SER
9
-129.85
-160.52
5
B
CYS
7
-126.88
-166.96
5
B
CYS
19
-93.25
-76.21
5
B
GLU
21
176.53
-29.24
5
B
DAL
23
121.03
53.47
5
B
PHE
24
-49.88
-176.41
5
B
LYS
28
165.68
-51.40
6
A
CYS
7
-130.04
-50.25
6
A
SER
9
-119.03
-161.66
6
B
GLU
21
-178.79
70.00
6
B
ARG
22
-163.68
-55.03
6
B
PHE
24
-54.14
-168.35
7
A
CYS
7
-127.05
-56.81
7
B
GLN
4
-160.39
104.53
7
B
CYS
19
-83.59
-71.14
7
B
DAL
20
62.32
97.53
7
B
GLU
21
80.43
39.47
7
B
ARG
22
-146.33
-48.89
7
B
DAL
23
107.94
60.72
7
B
PHE
24
-56.44
-177.25
7
B
THR
27
-109.22
-155.68
7
B
LYS
28
-172.84
130.41
7
B
PRO
29
-78.19
-156.73
8
B
VAL
2
-141.77
13.35
8
B
ASN
3
59.89
115.04
8
B
ARG
22
-96.26
-70.42
8
B
DAL
23
134.66
50.38
8
B
PHE
24
-49.12
178.96
9
A
CYS
7
-126.29
-63.53
9
B
DAL
20
88.29
-31.37
9
B
ARG
22
-146.94
-72.18
9
B
DAL
23
130.48
63.17
9
B
PHE
24
-59.38
-169.14
10
A
CYS
7
-126.53
-52.81
10
A
SER
9
-123.62
-152.94
10
B
ASN
3
51.66
80.52
10
B
CYS
19
-82.14
-71.56
10
B
GLU
21
179.05
46.52
10
B
ARG
22
-152.07
-48.52
10
B
PHE
24
-52.26
-174.33
10
B
LYS
28
-152.86
63.54
11
A
CYS
7
-135.44
-61.87
11
A
SER
9
-111.90
-147.33
11
B
CYS
19
-85.70
-72.90
11
B
GLU
21
-177.50
-35.24
11
B
DAL
23
103.76
63.05
11
B
PHE
24
-53.86
-169.41
12
A
ILE
2
-105.25
-91.56
12
A
CYS
7
-131.89
-64.52
12
A
SER
9
-113.34
-155.25
12
B
VAL
2
-141.56
12.85
12
B
ASN
3
-163.49
117.99
12
B
GLN
4
-160.05
49.17
12
B
CYS
19
-87.24
-71.68
12
B
PHE
24
-52.78
-172.67
12
B
THR
27
-103.84
77.85
13
A
SER
9
-121.71
-160.91
13
B
ASN
3
55.41
88.97
13
B
GLN
4
-160.37
71.63
13
B
CYS
19
-91.28
-72.37
13
B
GLU
21
-164.20
-38.47
13
B
PHE
24
-48.84
-179.65
14
A
CYS
7
-127.35
-58.18
14
A
CYS
20
-68.43
-176.24
14
B
CYS
19
-98.08
-75.92
14
B
GLU
21
-177.13
77.39
14
B
ARG
22
173.50
-63.74
14
B
PHE
24
-52.39
-172.55
15
A
CYS
7
-133.74
-73.47
15
A
SER
9
-115.76
-144.79
15
B
ASN
3
54.86
104.20
15
B
GLN
4
-160.24
99.76
15
B
DAL
20
69.98
96.64
15
B
GLU
21
77.38
41.77
15
B
ARG
22
-139.05
-58.60
15
B
PHE
24
-53.06
-173.13
16
A
SER
9
-134.83
-157.34
16
A
CYS
20
-61.15
-175.58
16
B
CYS
19
-82.78
-72.33
16
B
GLU
21
-115.67
50.44
16
B
ARG
22
-127.66
-69.05
16
B
DAL
23
126.38
56.63
16
B
PHE
24
-53.35
-173.88
16
B
THR
27
-84.50
-74.55
16
B
LYS
28
57.55
71.95
17
A
CYS
7
-131.25
-40.30
17
A
SER
9
-136.86
-153.20
17
A
CYS
20
-54.39
172.07
17
B
GLN
4
-160.53
107.59
17
B
CYS
19
-82.38
-70.52
17
B
DAL
20
88.67
-42.55
17
B
ARG
22
-159.84
-53.89
17
B
DAL
23
106.29
65.47
17
B
PHE
24
-62.81
-167.67
17
B
PRO
29
-77.89
-155.76
18
A
ILE
2
-101.73
-62.72
18
A
CYS
7
-124.04
-74.91
18
A
CYS
20
-59.56
-170.13
18
B
GLN
4
-160.47
99.69
18
B
GLU
21
177.23
71.57
18
B
ARG
22
176.65
-41.72
18
B
DAL
23
91.35
63.01
18
B
PHE
24
-53.04
-173.06
18
B
LYS
28
56.58
102.74
18
B
PRO
29
-77.44
-90.87
19
A
CYS
7
-136.45
-55.60
19
A
CYS
20
-58.06
173.28
19
B
ARG
22
-179.83
-55.59
19
B
DAL
23
107.58
62.00
19
B
PHE
24
-55.82
-170.17
19
B
LYS
28
71.85
61.97
20
A
SER
9
-163.01
-166.80
20
B
ASN
3
54.17
101.57
20
B
GLN
4
-160.15
98.74
20
B
CYS
19
-94.80
-65.50
20
B
PHE
24
-50.13
179.48
20
B
LYS
28
-163.00
93.10
20
B
PRO
29
-77.42
-91.03
Insulin A chain/Insulin B chain
closest to the average, model 1
NMR Structure of human insulin mutant GLY-B20-D-ALA, GLY-B23-D-ALA PRO-B28-LYS, LYS-B29-PRO, 20 Structures
1
N
N
2
N
N
A
ILE
2
A
ILE
2
HELX_P
A
CYS
7
A
CYS
7
1
1
6
A
SER
12
A
SER
12
HELX_P
A
GLU
17
A
GLU
17
1
2
6
A
ASN
18
A
ASN
18
HELX_P
A
CYS
20
A
CYS
20
5
3
3
B
CYS
7
B
CYS
7
HELX_P
B
CYS
19
B
CYS
19
1
4
13
disulf
2.020
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
11
A
SG
CYS
11
1_555
disulf
2.019
A
CYS
7
A
SG
CYS
7
1_555
B
CYS
7
B
SG
CYS
7
1_555
disulf
2.018
A
CYS
20
A
SG
CYS
20
1_555
B
CYS
19
B
SG
CYS
19
1_555
covale
1.305
B
CYS
19
B
C
CYS
19
1_555
B
DAL
20
B
N
DAL
20
1_555
covale
1.302
B
DAL
20
B
C
DAL
20
1_555
B
GLU
21
B
N
GLU
21
1_555
covale
1.303
B
ARG
22
B
C
ARG
22
1_555
B
DAL
23
B
N
DAL
23
1_555
covale
1.306
B
DAL
23
B
C
DAL
23
1_555
B
PHE
24
B
N
PHE
24
1_555
HORMONE
HORMONE, HUMAN INSULIN, MUTANT
INS_HUMAN
UNP
1
90
P01308
GIVEQCCTSICSLYQLENYCN
INS_HUMAN
UNP
2
25
P01308
FVNQHLCGSHLVEALYLVCGERGFFYTPKT
90
110
2L1Y
1
21
P01308
A
1
1
21
25
54
2L1Y
1
30
P01308
B
2
1
30
2
GLY
SEE REMARK 999
DAL
20
2L1Y
B
P01308
UNP
44
20
2
GLY
SEE REMARK 999
DAL
23
2L1Y
B
P01308
UNP
47
23
2
PRO
ENGINEERED MUTATION
LYS
28
2L1Y
B
P01308
UNP
52
28
2
LYS
ENGINEERED MUTATION
PRO
29
2L1Y
B
P01308
UNP
53
29
BINDING SITE FOR RESIDUE DAL B 20
Software
4
BINDING SITE FOR RESIDUE DAL B 23
Software
5
B
TYR
16
B
TYR
16
4
1_555
B
LEU
17
B
LEU
17
4
1_555
B
CYS
19
B
CYS
19
4
1_555
B
GLU
21
B
GLU
21
4
1_555
A
ASN
21
A
ASN
21
5
1_555
B
TYR
16
B
TYR
16
5
1_555
B
GLU
21
B
GLU
21
5
1_555
B
ARG
22
B
ARG
22
5
1_555
B
PHE
24
B
PHE
24
5
1_555